HAL (France)open access
Targeted radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: From beta-emitters to next-generation alpha therapies
Somatostatin analogues, Targeted alpha therapy, Neuroendocrine tumor, 1, 2, Peptide receptor radionuclide therapy, Theranostic, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 284149
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.